# ArtiBest for Knee Osteoarthritis

> **NCT06994546** · NA · RECRUITING · sponsor: **Maxigen Biotech Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Knee Osteoarthristis

## Interventions

- **DEVICE:** ArtiBest ® Intra articular Injection

## Key facts

- **NCT ID:** NCT06994546
- **Lead sponsor:** Maxigen Biotech Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-11
- **Primary completion:** 2025-11-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06994546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06994546, "ArtiBest for Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06994546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*